GlassScriptPhysician profile
David H Daniels
NPI 1972558229
$2,456.30
in general payments reported to CMS, 2019-2025
39 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $247 · 2021: $546 · 2022: $583 · 2023: $48.01 · 2024: $164 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $256.17 | 2021-2024 | Botox |
| Amgen INC. | $242.53 | 2019-2022 | |
| Amarin Pharma, INC. | $154.21 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $137.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $130.21 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.83 | 2019-2022 | |
| Pfizer INC. | $95.81 | 2019-2022 | |
| Novo Nordisk INC | $95.61 | 2019-2021 | |
| Neotract INC. | $94.58 | 2019-2020 | |
| Medtronic, INC. | $83.42 | 2021-2025 | Corevalve Evolut R |
| Biogen, INC. | $82.80 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $77.54 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.82 | 2022-2025 | |
| Edap Technomed INC | $72.00 | 2024 | |
| Urogen Pharma, INC. | $65.90 | 2024-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.